Keryx Refocuses On Mid-Stage Pipeline, Delays Phase III Study Of Perifosine In Kidney Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Sulonex Phase III failure in diabetic nephropathy leads firm to cut workforce, some early-stage drug candidate research.